New York State Common Retirement Fund Citius Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.58 - $1.03 $44,576 - $79,161	-76,856 Reduced 98.55%	1,134 $1,000
Q4 2023 Feb 01, 2024	SELL	$0.65 - $0.86 $236 - $313	-364 Reduced 0.46%	77,990 $59,000
Q3 2023 Nov 07, 2023	BUY	$0.65 - $1.25 $880 - $1,692	1,354 Added 1.76%	78,354 $54,000
Q2 2023 Aug 07, 2023	BUY	$1.08 - $1.65 $83,160 - $127,050	77,000 New	77,000 $92,000
Q2 2022 Aug 04, 2022	SELL	$0.88 - $1.87 $44,884 - $95,379	-51,005 Reduced 98.2%	935 $1,000
Q4 2021 Feb 02, 2022	SELL	$1.51 - $2.2 $292 - $426	-194 Reduced 0.37%	51,940 $80,000
Q3 2021 Nov 02, 2021	SELL	$1.74 - $2.6 $78,588 - $117,431	-45,166 Reduced 46.42%	52,134 $106,000
Q2 2021 Aug 02, 2021	BUY	$1.51 - $4.23 $146,923 - $411,579	97,300 New	97,300 $339,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.